Provides an overview of current US government agency programming in global health R&D, highlights areas of success and areas for improvment, and provides recommendations to improve strategic alignment and coordination of US-supported global health R&D activities.
Outlines the need for greater interagency coordination among US government agencies and programs engaged in global health R&D and provides a set of recommendations for achieving this goal.
Fifth annual GHTC policy report providing recommendations that Congress and the Administration can use to leverage the United States' important role in global health R&D.
Examines how the US Food and Drug Administration (FDA) can maximize its investment and global impact. This brief offers actionable recommendations that the FDA can implement to strengthen the United States’ legacy in global health.
Find out about GHTC’s membership options and the benefits of becoming a member.
Learn MoreWe bring together nonprofits, academic institutions, and aligned businesses that are committed to advancing health equity through innovation.
